drugset / Trial / NCT04836806
Cetirizine and Famotidine for COVID-19
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of cetirizine and famotidine in reducing the duration of symptoms in patients with COVID-19. Secondary aims are to determine if cetirizine and famotidine decrease severity and duration of symptoms, incidence of hospitalizations, ICU admissions, and death.
Timeline
- Start
- 2021-08
- Primary completion
- 2022-07
- Completion
- 2022-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cetirizine | Other / unclassified | 10 mg | — |
| Subject | Famotidine | Other / unclassified | 20 mg | — |